Although STZ and GLP-1 have been broadly used in diabetes research and therapy, the underlying mechanisms of STZ-induced hyperglycemia or GLP-1-mediated β-cell protection, especially in their influences on global gene expression profiles of pancreatic islets, remain elusive. This evidence concerns the gene GLP1R and diabetes mellitus.